Nanomix Completes Changes to Corporate Name and Ticker Symbol
Nanomix Corporation (OTCBB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, today announced the completion of its name change...
Boston Therapeutics Announces $8.4 Million Convertible Placement in Conjunction with Nanomix Reverse Merger
Boston Therapeutics, Inc. (the “Company”) (OTCQB:BTHE) and merger partner Nanomix, Inc. (“Nanomix”), a leader in the development of mobile, affordable, point-of-care diagnostics, today announced...